Literature DB >> 20182849

Use of a diagnostic positron emission tomography-computed tomography system for planning radiotherapy positioning: distortion of the tabletop.

Yoshiomi Kishida1, Hitoshi Ikushima, Motoharu Sasaki, Yasuo Hara, Masataka Oita, Hiromu Nishitani.   

Abstract

PURPOSE: The aim of this study was to evaluate distortion of the tabletop in a diagnostic positron emission tomography-computed tomography (PET-CT) system to determine its suitability for planning radiotherapy positioning.
MATERIALS AND METHODS: Distortion of the tabletop was compared among PET-CT, lineac CT, and CT simulator systems. A phantom or angiography catheter was fixed to the tabletop and imaged after iron plate weight loading. The acquired images were analyzed using radiotherapy planning software. Distortion of the tabletop was measured based on the displayed coordinates.
RESULTS: Sinking represented the greatest distortion of the tabletop in all systems. Using the same baseline, the maximum sinking were -0.4, -0.2, and +0.4 cm, respectively. The distortion of the tabletop in the PET-CT system was more similar to that in the lineac CT than in the CT simulator system.
CONCLUSION: Distortion of the tabletop in a diagnostic PET-CT system may be within the acceptable range to allow its use for planning radiotherapy positioning.

Entities:  

Mesh:

Year:  2010        PMID: 20182849     DOI: 10.1007/s11604-009-0398-0

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  7 in total

1.  [Quality control (QC) of CT on rail system (FOCAL Unit) with a micro-multi leaf collimator (mMLC) using new GafChromic film for stereotactic radiotherapy].

Authors:  M Oita; Y Takegawa; H Yagi; H Ikushima; K Osaki; S Furutani; M Sasaki; M Tominaga; Y Nishimoto; H Nishitani
Journal:  Nihon Hoshasen Gijutsu Gakkai Zasshi       Date:  2006-05-20

2.  Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer.

Authors:  Arnold C Paulino; Mary Koshy; Rebecca Howell; David Schuster; Lawrence W Davis
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-04-01       Impact factor: 7.038

3.  Hybrid PET-CT simulation for radiation treatment planning in head-and-neck cancers: a brief technical report.

Authors:  Dwight E Heron; Regiane S Andrade; John Flickinger; Jonas Johnson; Sanjiv S Agarwala; Andrew Wu; Shalom Kalnicki; Norbert Avril
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-12-01       Impact factor: 7.038

4.  Effects of radiotherapy planning with a dedicated combined PET-CT-simulator of patients with non-small cell lung cancer on dose limiting normal tissues and radiation dose-escalation: a planning study.

Authors:  Dirk De Ruysscher; Stofferinus Wanders; Andre Minken; Aniek Lumens; Jacqueline Schiffelers; Cissie Stultiens; Serve Halders; Liesbeth Boersma; Angela van Baardwijk; Tom Verschueren; Monique Hochstenbag; Gabriel Snoep; Brad Wouters; Sebastiaan Nijsten; Søren M Bentzen; Marinus van Kroonenburgh; Michel Ollers; Philippe Lambin
Journal:  Radiother Oncol       Date:  2005-07-12       Impact factor: 6.280

5.  Radiotherapy planning: PET/CT scanner performances in the definition of gross tumour volume and clinical target volume.

Authors:  Ernesto Brianzoni; Gloria Rossi; Sergio Ancidei; Alfonso Berbellini; Francesca Capoccetti; Carla Cidda; Paola D'Avenia; Sara Fattori; Gian Carlo Montini; Gianluca Valentini; Alfredo Proietti; Carlo Algranati
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-08-26       Impact factor: 9.236

6.  The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer.

Authors:  Hani Ashamalla; Sameer Rafla; Kapila Parikh; Bahaa Mokhtar; Ganesh Goswami; Shravan Kambam; Hussain Abdel-Dayem; Adel Guirguis; Pamela Ross; Alex Evola
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-06-24       Impact factor: 7.038

Review 7.  Image-guided cancer therapy using PET/CT.

Authors:  Jeffrey T Yap; Jonathan P J Carney; Nathan C Hall; David W Townsend
Journal:  Cancer J       Date:  2004 Jul-Aug       Impact factor: 3.360

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.